Overview
TWST market data
Price History
TWST price chart · 1M
- O
- 148.74
- H
- 153.70
- L
- 148.74
- C
- 150.09
- Vol
- 60,596.00
- Source
- US equities market feed
- Observed
- Aug 26, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $148.74
- Previous Close
- $151.63
- Day High
- $153.70
- Day Low
- $148.74
- 52 Week High
- $154.75
- 52 Week Low
- $41.52
- 7 Day Return
- +5.48%
- 30 Day Return
- +73.75%
- 90 Day Return
- +117.23%
- 1 Year Return
- +219.74%
- Daily Notional Volume
- $9.1M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.30 Diluted earnings per share over the trailing twelve months.
- Beta
- 2.22 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -31.7% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $23.30 – $145.93 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $8.2B · P/B 3.59 · P/S 19.07.
Company News
8-K filing — Twist Bioscience Corp (TWST)SEC EDGAR · Aug 19, 2026, 9:24 PM
Twist Bioscience Stock Resilient Despite Scorpion Capital Short ReportBenzinga · Aug 19, 2026, 8:11 PM
Watching Twist Bioscience; Scorpion Capital Issues Report On Co, States They Hold A Short PositionBenzinga · Aug 19, 2026, 7:37 PM
Twist Bioscience Stock Hits 52-Week High - Here's WhyBenzinga · Aug 19, 2026, 5:46 PM
Twist Bioscience shares are trading higher after Anthropic named the company as an independent evaluator in a protein design campaign using its Claude Opus 4.8 and Mythos Preview AI models.Benzinga · Aug 19, 2026, 2:46 PM
Estee Lauder, Moderna, Merck And Other Big Stocks Moving Higher On WednesdayBenzinga · Aug 19, 2026, 2:08 PM
Twist Bioscience shares are trading higher after Piper Sandler maintained its Overweight rating on the stock and raised its price target from $85 to $115.Benzinga · Aug 5, 2026, 5:18 PM
Piper Sandler Maintains Overweight on Twist Bioscience, Raises Price Target to $115Benzinga · Aug 5, 2026, 3:57 PM
Reported Earlier, Twist Bioscience Prices Upsized Public Offering Of 3,125,000 Common Shares At $96.00 Per Share To Fund R&D And Manufacturing ExpansionBenzinga · Aug 5, 2026, 6:45 AM
Twist Bioscience Announces $250M Public Stock OfferingBenzinga · Aug 4, 2026, 8:05 PM